|
CN112125899A
|
|
Pyrroloquinoline quinone disodium salt crystal, preparation method thereof and composition containing pyrroloquinoline quinone disodium salt crystal
|
|
CN111690690A
|
|
Saccharomyces cerevisiae for producing farnesene
|
|
CN109609424A
|
|
For producing the Escherichia coli of farnesene
|
|
CN109486695A
|
|
For producing the Yarrowia lipolytica of farnesene
|
|
US2017042817A1
|
|
Method and system for producing high purity vancomycin hydrochloride
|
|
CN107021916A
|
|
A kind of preparation method of trans -3- methyl -5- benzylamino piperidines
|
|
CN101544668A
|
|
Method for preparing 2,4-di-double-bond 15-carbon phosphonate
|
|
CN101759577A
|
|
Synthesis method of (R)-moprolol
|
|
CN101504393A
|
|
HPLC measuring method for d-biotin and its impurity content
|
|
CN101402604A
|
|
Synthesis of 1,3-dibenzyl-4,5-cis-bihydroxymethyl-2- imidazolone
|
|
CN101402605A
|
|
Process for producing 1,3-dibenzyl-4,5-cis-bihydroxymethyl-2-imidazolone
|
|
CN101480375A
|
|
Coenzyme Q10 intravenous transfusion and preparation method thereof
|
|
CN101613396A
|
|
Noncrystal vancomycin hydrochloride and its production and use and its pharmaceutical composition
|
|
CN101461450A
|
|
Method for replenishing carotenoids in vivo for animal by drinking water
|
|
CN101397333A
|
|
De-hydroxyl vancomycin, preparation method thereof, medicament composition and use thereof
|
|
CN101371841A
|
|
Crystallization type Entecavir formulation as well as preparation method and use thereof
|
|
CN101328111A
|
|
Purification process of citral
|
|
CN101292985A
|
|
Levofloxacin Lactate freeze-dried injection and preparation method thereof
|
|
CN101289449A
|
|
2,6-di-nitrogen-containing substituted purine derivatives, preparation method and applications thereof
|
|
CN101260134A
|
|
Precipitation method for vancomycin
|
